Serrumab's multiple neutralizing capacities to scorpion toxins (2013)
- Authors:
- USP affiliated authors: BRAGA, ELIANE CANDIANI ARANTES - FCFRP ; BARBOSA, JOSE ELPIDIO - FMRP
- Unidades: FCFRP; FMRP
- Subjects: VENENOS DE ORIGEM ANIMAL; ESCORPIÕES; TOXINAS (ISOLAMENTO E PURIFICAÇÃO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Congress of the Pan-American Section of the International Society on Toxinology
-
ABNT
PUCCA, Manuela Berto et al. Serrumab's multiple neutralizing capacities to scorpion toxins. 2013, Anais.. Guarujá: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2013. . Acesso em: 29 dez. 2025. -
APA
Pucca, M. B., Cerni, F. A., Peigneur, S., Arantes, E. C., Tytgat, J., & Barbosa, J. E. (2013). Serrumab's multiple neutralizing capacities to scorpion toxins. In Abstracts. Guarujá: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. -
NLM
Pucca MB, Cerni FA, Peigneur S, Arantes EC, Tytgat J, Barbosa JE. Serrumab's multiple neutralizing capacities to scorpion toxins. Abstracts. 2013 ;[citado 2025 dez. 29 ] -
Vancouver
Pucca MB, Cerni FA, Peigneur S, Arantes EC, Tytgat J, Barbosa JE. Serrumab's multiple neutralizing capacities to scorpion toxins. Abstracts. 2013 ;[citado 2025 dez. 29 ] - Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities
- Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon
- Human antibody fragments (scFv 2A) inhibit biochemical and immunological effects of Tityus serrulatus venon
- A human antibody fragment specific to Tityus serrulatus Ts1 major toxin recognizes other potential sodium channel toxins and could be used as a new ativenom
- Human antibody fragments inhibit the action of TsTx-I toxin in vitro and the lethality of the Tityus serrulatus venom in vivo
- Human antibody fragments (scFv) produced by phage display technology recognize Tityus serrulatus venom and inhibit the action of TsTx-1 toxin on 'Na POT.+' channels
- Anti-peptide antibody detecting a neo-antigen on the cri stump left on erythrocytes after proteolysis
- Expressão do receptor para complemento tipo 1(CR1) em eritrócitos de pacientes com leishmaniose visceral
- Complement receptor type 1 (CRI) expression on erythrocytes of patients with kala-azar
- Phage display as a novel promising antivenom therapy: a review
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
